Streetbeat News

Stock Prices

LOGI

Logitech International's shares are trading lower following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:47 am

GPC

Genuine Parts Company (GPC) shares declined following the release of mixed Q3 financial results and a reduction in FY24 EPS guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:47 am

GE

GE Aerospace shares declined following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:42 am

LXEO

Lexeo Therapeutics announced that interim data from its ongoing Phase 1/2 trial of LX1001 will be presented as a late-breaking oral presentation at the CTAD Conference. This highlights the potential significance of the trial results.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:38 am

BIIB

Biogen is set to present new data from its felzartamab clinical development program at Kidney Week 2024, including conclusive Phase 2 IGNAZ study results for IgA nephropathy.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:37 am

ARQT

OGN

TMDX

The article highlights three oversold health care stocks with potential for gains in Q4: Organon & Co (OGN), Arcutis Biotherapeutics Inc (ARQT), and TransMedics Group Inc (TMDX). These stocks have RSI values near or below 30, indicating they are oversold. Organon is set to release its Q3 2024 results on Oct. 31, Arcutis received Health Canada approval for ZORYVE Foam, and TransMedics will release its Q3 results on Oct. 28.

Portfolio Pulse from Avi Kapoor

October 22, 2024 | 11:36 am

LMT

Lockheed Martin has raised its FY24 outlook, increasing its GAAP EPS guidance to $26.65 and narrowing its sales guidance to $71.25 billion. This reflects a positive adjustment compared to previous estimates.

Portfolio Pulse from Mohit Manghnani

October 22, 2024 | 11:35 am

LMT

Lockheed Martin has increased its stock buyback authorization by $3 billion, bringing the total to $10.3 billion. This move indicates confidence in the company's financial health and may positively impact its stock price.

Portfolio Pulse from Mohit Manghnani

October 22, 2024 | 11:32 am

LMT

Lockheed Martin reported Q3 2024 earnings per share of $6.84, surpassing the analyst estimate of $6.50. However, sales of $17.104 billion fell short of the expected $17.351 billion.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:30 am

SFST

Southern First Bancshares reported Q3 2024 earnings per share of $0.54, surpassing the expected $0.38, but sales of $20.59M fell short of the $20.81M estimate. Sales increased by 6.44% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:29 am